ProPhase Labs (PRPH) Misses Q3 EPS by 33c; Reports Cash and Cash Equivalents of $22.9M

ProPhase Labs (NASDAQ: PRPH) reported Q3 EPS of ($0.26), $0.33 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $9.5 million versus the consensus estimate of $9.08 million.

For earnings history and earnings-related data on ProPhase Labs (PRPH) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• MillerKnoll, Inc. (MLKN) Tops Q4 EPS by 4c
• Micron Technology (MU) Tops Q3 EPS by $4.62, Guidance Beats